Truist Financial’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-33,726
Closed -$379K 2619
2023
Q1
$379K Hold
33,726
﹤0.01% 2140
2022
Q4
$447K Buy
+33,726
New +$443K ﹤0.01% 2039
2022
Q3
Sell
-19,166
Closed -$283K 2595
2022
Q2
$283K Buy
+19,166
New +$314K ﹤0.01% 2255
2021
Q3
Sell
-32,509
Closed -$436K 2764
2021
Q2
$436K Hold
32,509
﹤0.01% 2149
2021
Q1
$388K Hold
32,509
﹤0.01% 2131
2020
Q4
$402K Sell
32,509
-181
-0.6% -$1.95K ﹤0.01% 1976
2020
Q3
$341K Sell
32,690
-347
-1% -$4.41K ﹤0.01% 1942
2020
Q2
$462K Buy
33,037
+232
+0.7% +$3.16K ﹤0.01% 1658
2020
Q1
$386K Sell
32,805
-2,858
-8% -$37.8K ﹤0.01% 1704
2019
Q4
$505K Buy
+35,663
New +$438K ﹤0.01% 1854

Other funds holding INVA

Truist Financial's INVA Position: Q2 2023 in Review

Truist Financial sold out of Innoviva (INVA) in Q2 2023, closing a stake of 33,726 shares — an estimated $379K sold.

Truist Financial first reported a position in INVA in Q4 2019 and held it in 10 quarters. The position peaked at $505K in Q4 2019. 199 funds tracked by Wall St. Rank hold INVA as of Q2 2023.

  • Truist Financial reported no remaining Innoviva position as of Q2 2023 after selling out during the quarter.
  • Truist Financial sold 33,726 Innoviva shares in Q2 2023, an estimated $379K.
  • Truist Financial first reported a position in Innoviva in Q4 2019 and held it in 10 quarters.
  • Truist Financial's Innoviva position peaked at $505K in Q4 2019.
  • 199 funds tracked by Wall St. Rank held Innoviva as of Q2 2023.

Based on Truist Financial's 13F filing for Q2 2023, filed 1 Aug 2023.